Cryptosporidium parvum-Specific CD4 Th1 Cells from Sensitized Donors Responding to Both Fractionated and Recombinant Antigenic Proteins

Infection and Immunity

Volumn 72, Issue 3, 2004, Pages 1306-1310

  Gomez Morales, Maria Angeles ^a   Mele, Raffaella ^a   Ludovisi, Alessandra ^a   Bruschi, Fabrizio ^b   Tosini, Fabio ^a   Pozio, Edoardo ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; EPITOPE; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 5; RECOMBINANT ANTIGEN; RECOMBINANT PROTEIN; SA35 PEPTIDE; SA40 PEPTIDE; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; UNCLASSIFIED DRUG;

ARTICLE; CELL CLONE; CELLULAR IMMUNITY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; FRACTIONATION; HUMAN; IMMUNE RESPONSE; INTERFERON PRODUCTION; ION EXCHANGE CHROMATOGRAPHY; NONHUMAN; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SPOROZOITE; TH1 CELL;

ANIMALS; ANTIGENS, PROTOZOAN; CELL DIVISION; CELL LINE; CLONE CELLS; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; CYTOKINES; HUMANS; IMMUNODOMINANT EPITOPES; PHENOTYPE; PROTOZOAN PROTEINS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECOMBINANT PROTEINS; TH1 CELLS;

EID: 1342323827     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.3.1306-1310.2004     Document Type: Article

References (45)

1. Aguirre, S. A., P. H. Mason, and L. E. Perryman. 1994. Susceptibility of major histocompatibility complex (MHC) class I- and MHC class II-deficient mice to Cryptosporidium parvum infection. Infect. Immun. 62:697-699.
2. Amadi, B., M. Mwiya, J. Musuku, A. Watuka, S. Sianongo, A. Ayoub, and P. Kelly. 2002. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet 360:1375-1380.
3. Barnes, D. A., A. Bonnin, J. X. Huang, L. Gousset, J. Wu, J. Gut, P. Doyle, J. F. Dubremetz, H. Ward, and C. Petersen. 1998. A novel multi-domain mucin-like glycoprotein of Cryptosporidium parvum mediates invasion. Mol. Biochem. Parasitol. 96:93-110.
4. Blanshard, C., A. M. Jackson, D. C. Shanson, N. Francis, and B. G. Gazzard. 1992. Cryptosporidiosis in HIV-seropositive patients. Q. J. Med. 85:813-823.
5. Bonafonte, M. T., M. L. Smith, and J. R. Mead. 2000. A 23-kDa recombinant antigen of Cryptosporidium parvum induces a cellular immune response on in vitro stimulated spleen and mesenteric lymph node cells from infected mice. Exp. Parasitol. 96:32-41.
6. Cacciò, S., E. Pinter, R. Fantini, I. Mezzaroma, and E. Pozio. 2002. Human infection with Cryptosporidium felis: case report and literature review. Emerg. Infect. Dis. 8:85-86.
7. Cosyns, M., S. Tsirkin, R. Jones, R. Flavell, H. Kikutani, and A. R. Hayward. 1998. Requirement of CD40-CD40 ligand interaction for elimination of Cryptosporidium parvum from mice. Infect. Immun. 66:603-607.
8. Crabb, J. H. 1998. Antibody-based immunotherapy of cryptosporidiosis. Adv. Parasitol. 40:121-149.
9. Eichelberger, M. C., P. Suresh, and J. E. Rehg. 2000. Protection from Cryptosporidium parvum infection by gamma delta T cells in mice that lack alpha beta T cells. Comp. Med. 50:270-276.
10. Farthing, M. J. G. 2000. Clinical aspects of human cryptosporidiosis, p. 50-74. In F. Petry (ed.), Cryptosporidiosis and microsporidiosis. Contribution to microbiology, vol. 6. Karger, Basel, Switzerland.
11. Fichtenbaum, C. J., D. J. Ritchie, and W. G. Powderly. 1993. Use of paromycin for treatment of cryptosporidiosis in patients with AIDS. Clin. Infect. Dis. 16:298-300.
12. Flanigan, T., C. Whalen, J. Turner, R. Soave, J. Toerner, D. Havlir, and D. Kotler. 1992. Cryptosporidium infection and CD4 counts. Ann. Intern. Med. 116:840-842.
13. Giacometti, A., F. Burzacchini, O. Cirioni, F. Barchiesi, M. Dini, and G. Scalise. 1999. Efficacy of treatment with paromomycin, azithromycin and nitazoxanide in a patient with disseminated cryptosporidiosis. Eur. J. Clin. Microbiol. Infect. Dis. 18:885-889.
14. Gomez Morales, M. A., and E. Pozio. 2002. Humoral and cellular immunity against Cryptosporidium infection. Curr. Drug Targets Immun. Endocr. Metabol. Disord. 2:291-301.
15. Gomez Morales, M. A., C. M. Ausiello, A. Guarino, F. Urbani, M. I. Spagnuolo, C. Pignata, and E. Pozio. 1996. Severe, protracted intestinal cryptosporidiosis associated with interferon gamma deficiency: pediatric case report. Clin. Infect. Dis. 22:848-850.
16. Gomez Morales, M. A., C. M. Ausiello, F. Urbani, and E. Pozio. 1995. Crude extract and recombinant protein of Cryptosporidium parvum oocysts induce proliferation of human peripheral blood mononuclear cells in vitro. J. Infect. Dis. 172:211-216.
17. Gomez Morales, M. A., G. La Rosa, A. Ludovisi, A. M. Onori, and E. Pozio. 1999. Cytokine profile induced by Cryptosporidium antigen in peripheral blood mononuclear cells from immunocompetent and immunosuppressed persons with cryptosporidiosis. J. Infect. Dis. 179:967-973.
18. Greenberg, P. C., and J. Cello. 1996. Treatment of severe diarrhea caused by Cryptosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS. J. Acquir. Immune Defic. Syndr. Hum. Retrovir. 13:348-354.
19. Hamour, A. A., A. Bonnington, B. Hawthorne, and E. G. Wilkins. 1993. Successful treatment of AIDS related cryptosporidial sclerosing cholangitis. AIDS 7:1449-1451.
20. Hayward, A. R., L. Levy, F. Facchetti, L. Notarangelo, H. D. Ochs, A. Etzioni, J. Y. Bonnefoy, M. Cosyns, and A. Weinberg. 1997. Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J. Immunol. 158:977-983.
21. Hayward, A. R., M. Cosyns, M. Jones, and E. M. Ponnuraj. 2001. Marrow-derived CD40-positive cells are required for mice to clear Cryptosporidium parvum infection. Infect. Immun. 69:1630-1634.
22. Hunt, E., Q. Fu, M. U. Armstrong, D. K. Rennix, D. W. Webster, J. A. Galanko, W. Chen, E. M. Weaver, R. A. Argenzio, and J. M. Rhoads. 2002. Oral bovine serum concentrate improves cryptosporidial enteritis in calves. Pediatr. Res. 51:370-376.
23. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
24. Lagler, H., M. Willheim, F. Traunmuller, et al. 2003. Cellular profile of cytokine production in a patient with visceral leishmaniasis: gammadelta+ T cells express both type 1 cytokines and interleukin-10. Scand. J. Immunol. 57:291-295.
25. Lean, I., V. McDonald, and R. C. G. Pollok. 2002. The role of cytokines in the pathogenesis of Cryptosporidium infection. Curr. Opin. Infect. Dis. 15:229-234.
26. Levitz, S. M., H. L. Mathews, and J. W. Murphy. 1995. Direct antimicrobial activity of T cells. Immunol. Today 16:387-391.
27. Lukin, K., M. Cosyns, T. Mitchell, M. Saffry, and A. R. Hayward. 2000. Eradication of Cryptosporidium parvum infection by mice with ovalbumin-specific T cells. Infect. Immun. 68:2663-2670.
28. McDonald, V., and G. J. Bancroft. 1994. Mechanisms of innate and acquired resistance to Cryptosporidium parvum infection in SCID mice. Parasite Immunol. 16:315-320.
29. Mele, R., M. A. Gomez Morales, F. Tosini, and E. Pozio. 2003. Indinavir reduces Cryptosporidium parvum infection in both in vitro and in vivo models. Int. J. Parasitol. 33:757-764.
30. Moretto, M., B. Durell, J. D. Schwartzman, and I. A. Khan. 2001. Gamma delta T cell-deficient mice have a down-regulated CD8+ T cell immune response against Encephalitozoon cuniculi infection. J. Immunol. 166:7389-7397.
31. Moss, D. M., C. L. Chappell, P. C. Okhuysen, et al. 1998. The antibody response to 27-, 17-, and 15-kDa Cryptosporidium antigens following experimental infection in humans. J. Infect. Dis. 178:827-833.
32. Nisini, R., G. Romagnoli, M. J. Gomez, et al. 2001. Antigenic properties and processing requirements of 65-kilodalton mannoprotein, a major antigen target of anti-Candida human T-cell response, as disclosed by specific human T-cell clones. Infect. Immun. 69:3728-3736.
33. Nord, J., P. Ma, D. DiJohn, S. Tzipori, and C. O. Tacket. 1990. Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhea in AIDS patients. AIDS 4:581-584.
34. Okhuysen, P. C., C. L. Chappell, C. R. Sterling, W. Jakubowski, and H. L. DuPont. 1998. Susceptibility and serologic response of healthy adults to reinfection with Cryptosporidium parvum. Infect. Immun. 66:441-443.
35. Pozio, E., G. Rezza, A. Boschini, et al. 1997. Clinical cryptosporidiosis and human immunodeficiency virus (HIV)-induced immunosuppression: findings from a longitudinal study of HIV-positive and HIV-negative former injection drug users. J. Infect. Dis. 176:969-975.
36. Ranucci, L., H. M. Muller, G. La Rosa, et al. 1993. Characterization and immunolocalization of a Cryptosporidium parvum protein containing repeated amino acids motifs. Infect. Immun. 61:2347-2356.
37. Rossignol, J. F. A., A. Ayoub, and M. S. Ayers. 2001. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of nitazoxanide. J. Infect. Dis. 184:103-106.
38. Sagodira, S., S. Iochmann, M. N. Mevelec, I. Dimier-Poisson, and D. Bout. 1999. Nasal immunization of mice with Cryptosporidium parvum DNA induces systemic and intestinal immune responses. Parasite Immunol. 21:507-516.
39. Tosini, F., S. M. Cacciò, A. Tamburrini, G. La Rosa, and E. Pozio. 1999. Identification and characterisation of three antigenic proteins from Cryptosporidium parvum sporozoites using a DNA library expressing poly-histidine tagged peptides. Int. J. Parasitol. 29:925-933.
40. Tosini, F., A. Agnoli, R. Mele, H. M. A. Gomez Morales, and E. Pozio. A new modular protein of Cryptosporidium parvum, with ricin B and LCCL domains, expressed in the sporozoite invasive stage. Mol. Biochem. Parasitol., in press.
41. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350-4354.
42. Tzipori, S., D. Roberton, and C. Chapman. 1986. Remission of diarrhoea due to cryptosporidiosis in an immunodeficient child treated with hyperimmune bovine colostrum. Br. Med. J. 293:1276-1277.
43. Tzipori, S., D. Roberton, D. A. Cooper, and L. White. 1987. Chronic cryptosporidial diarrhoea and hyperimmune cow colostrum. Lancet 11:344-345.
44. Waters, W. R., and J. A. Harp. 1996. Cryptosporidium parvum infection in T-cell receptor (TCR)-alpha- and TCR-delta-deficient mice. Infect. Immun. 64:1854-1857.
45. Whitmire, W. M., and J. A. Harp. 1990. In vitro murine lymphocyte blastogenic responses to Cryptosporidium parvum. J. Parasitol. 76:450-452.